Visiongain Publishes Antimicrobial Hospital Curtains Market Report to 2031

22 February 2021
Pharma

Visiongain has published a new report on Antimicrobial Hospital Curtains Market Report to 2031. According to the Visiongain analysis, the global Antimicrobial Hospital Curtains market is anticipated to grow at a CAGR of XX% during the forecast period (2021-2031). The global Antimicrobial Hospital Curtains market is segmented by type (Reusable antimicrobial hospital curtains, Disposable antimicrobial hospital curtains), BY Material (Polyester, Polypropylene, Others), By End User (Hospitals, Nursing home, Ambulatory surgical centres, Others). By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa). The report includes detailed Profiles of Leading Antimicrobial Hospital Curtains Companies. PLUS COVID-19 Recovery Scenarios.

Global Antimicrobial Hospital Curtains Market was valued at US$XX billion in 2021 and is projected to reach a market value of US$ XX billion by 2031. The study covers detailed and insightful chapters on market overview, market segments, new developments, competitive landscape, strategic recommendations, key company analysis, market opportunities, pricing analysis, gap analysis, porter’s 5 forces model, company profiling, geographical analysis, and analytical overview of the market. The rising demand for lightweight, easy to install and safe antimicrobial curtains and increasing transmission of infectious disease are some of the factors driving the growth of Antimicrobial Hospital Curtains market.

COVID-19 Impact on the Global Antimicrobial Hospital Curtains Market
The global pandemic (COVID-19) is caused due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It imposes significant risk of transmission to healthcare workers, which reported high mortality rates. The pandemic has emerged the safety measures and enhance the healthcare awareness among population & hospitals which eventually increases the adoption of antimicrobial hospital curtains.

Market Driver
Increasing number of hospitals emerge the need of antimicrobial curtains
Large number of new-build hospitals are created, which provides single-room accommodation for patients. However, hospitals are significant factor of advanced healthcare system. The use of curtains is increasing in critical care, isolations, and various emergency areas in healthcare facilities. Numerous bacterial diseases are transmitted from person to person via hospital which includes equipment, bedside curtains. However, to prevent the spread of infection, various hospitals are installing antimicrobial curtains to prevent from transmission of infection.

Rising concern for transmission of infectious disease
The outbreaks of various hospital-acquired pathogens and its transmission have been reported in emergency areas, and Intensive Care Units. The curtains are frequently touched by visitors, nursing staff & patients, which increases the transmission of diseases causing pathogen. In hospital or clinic curtains various human pathogen are identified, such as Escherichia coli, Micrococcus species, Bacillus sp., Staphylococcus, and Staphylococcus aureus. However, some of these bacteria may persist on curtains even after laundry and become possible causes of infectious diseases. The antimicrobial hospital curtains are effective in reducing bacterial contamination as compared to standard curtains.

Market Opportunity

Antimicrobial hospital curtains reduce the risk of multidrug-resistant organisms (MDROs)
The use of antimicrobial curtains in hospital, have significant potential to reduce the transmission of multidrug-resistant organisms (MDROs) such as Pseudomonas aeruginosa, clostridium difficile, vancomycin-resistant enterococci (VRE), methicillin-resistant Staphylococcus aureus (MRSA). The use of antimicrobial curtains enables the healthcare workers, and staff to manage the risk of infection among patients. The antimicrobial component is applied to the curtains to reduce growth of bacteria, which can be develop in any type of an indoor environment. Additionally, the use of antimicrobial curtains controls microbial pathogen, methicillin resistant S. aureus (MRSA). However, it is vital to adapt sanitization guidelines to ensure effective elimination of microbes from hospital curtains.

Competitive Landscape
Endurocide Limited, Elers Medical, Hospital Curtain Solutions Inc., Hangzhou Xiang Jun Textile Flame Retardant Tech Co. Ltd, National Surgical Corporation, Anglo Middle East, Jiangsu Saikang Medical Equipment, RD Plast, Osho International are some of the key players contributing to the growth of the global antimicrobial hospital curtains market. The market players are adopting new strategies to stay competitive in the global market such as new product developments, joint ventures, mergers and acquisitions, and geographical expansions.

In November 2018, Endurocide Limited newly launched Endurocide Printed Curtains, making an appearance at the Australian College for Infection Prevention and Control Conference in Brisbane. The hospital curtains have both sporicidal & antimicrobial properties, visually bright and colourful disposable, ideal to use in children’s wards. The curtains are designed with the ability to trap and kill harmful pathogens on the surface of the fabric. In November 2018, Endurocide Limited announced its Endurocide Antimicrobial & Sporicidal Curtains cleared International Fabric Standard CG 147 against Mycobacteria tuberculosis.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes European Antibiotics Market Report 2021-2031

Penicillin segment holds majority of the market share owing to maximum prescription as well as the most generic manufacturers throughout the industry.

22 June 2021

Read

Visiongain Publishes Companion Diagnostics (CDx) Market Report 2021-2031

Over the last few years, companion diagnostics has gained widespread attention due to the technological advancements, growing demand for precision medicine, and accelerating demand for targeted therapy.

17 June 2021

Read

Visiongain Publishes Cellular Immunotherapy Market Report 2021-2031

Increasing prevalence of cancers and rising demand for advanced therapies for cancer treatment are the major factors driving the demand for cellular immunotherapies.

15 June 2021

Read

Visiongain Publishes Gene Therapy R&D Market Report 2021-2031

Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions.

14 June 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever